# OnCo record stablix (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/stablix/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "stablix" ;
  schema:name "Stablix"@en ;
  schema:description "Stablix does the opposite of protein degradation: its molecules recruit enzymes that strip the 'destroy me' tag off useful proteins so cells keep them. Cancer is one of its target areas, but all its work is still preclinical."@en ;
  schema:url <https://onco.cc/companies/stablix/>, <https://www.stablix.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.stablix.com/>, <https://www.stablix.com/copy-of-stablix-names-tony-kingsley-ceo>, <https://www.stablix.com/stablixandvertexestablishstrategiccollaborationtodiscoveranddeveloptargetedproteinstabil> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/targeted-therapy/> .